Manipulating brain connectivity with δ⁹-tetrahydrocannabinol: a pharmacological resting state FMRI study.

Manipulating brain connectivity with δ⁹-tetrahydrocannabinol: a pharmacological resting state FMRI study.

Resting state-functional magnetic resonance imaging (RS-FMRI) is a neuroimaging technique that allows repeated assessments of functional connectivity in resting state. While task-related FMRI is limited to indirectly measured drug effects in areas affected by the task, resting state can show direct...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Klumpers, L, Cole, D, Khalili-Mahani, N, Soeter, R, Te Beek, E, Rombouts, SA, van Gerven, J
Natura:	Journal article
Lingua:	English
Pubblicazione:	2012

Documenti analoghi

Dopamine-dependent architecture of cortico-subcortical network connectivity.
di: Cole, D, et al.
Pubblicazione: (2013)

Differential and distributed effects of dopamine neuromodulations on resting-state network connectivity.
di: Cole, D, et al.
Pubblicazione: (2013)

Biomarkers, designs, and interpretations of resting-state fMRI in translational pharmacological research: A review of state-of-the-Art, challenges, and opportunities for studying brain chemistry
di: Khalili-Mahani, N, et al.
Pubblicazione: (2017)

Toxicological properties of Δ9-tetrahydrocannabinol and cannabidiol
di: Černe Katarina
Pubblicazione: (2020-03-01)

The Pharmacokinetics of Δ<sup>9</sup>-Tetrahydrocannabinol in Sheep
di: Sarah A. Stevens, et al.
Pubblicazione: (2024-11-01)

Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity.
di: M Paola Castelli, et al.
Pubblicazione: (2014-01-01)

Chemistry and Pharmacology of Delta-8-Tetrahydrocannabinol
di: Maged S. Abdel-Kader, et al.
Pubblicazione: (2024-03-01)

Quantification and prediction of human fetal (-)-Δ9-tetrahydrocannabinol/(±)-11-OH-Δ9-tetrahydrocannabinol exposure during pregnancy to inform fetal cannabis toxicity
di: Aditya R. Kumar, et al.
Pubblicazione: (2025-01-01)

Δ9-tetrahydrocannabinol discrimination: Effects of route of administration in mice
di: Julie A. Marusich, et al.
Pubblicazione: (2023-12-01)

The dimerization of Δ9-tetrahydrocannabinolic acid A (THCA-A)
di: Arben Cuadari, et al.
Pubblicazione: (2019-09-01)

Acute human exposure assessment to tetrahydrocannabinol (Δ9‐THC)
di: European Food Safety Authority (EFSA), et al.
Pubblicazione: (2020-01-01)

Delta-9-tetrahydrocannabinol reduces the performance in sensory delayed discrimination tasks. A pharmacological-fMRI study in healthy volunteers
di: Carmen Walter, et al.
Pubblicazione: (2019-12-01)

Comparative Metabolomic Profiling of the Metabolic Differences of Δ9-Tetrahydrocannabinol and Cannabidiol
di: Qianru Rao, et al.
Pubblicazione: (2022-11-01)

Selective effects of Δ9-tetrahydrocannabinol on medium spiny neurons in the striatum.
di: Mónica R Fernández-Cabrera, et al.
Pubblicazione: (2018-01-01)

Tolerance and dependence to Δ9-tetrahydrocannabinol in rhesus monkeys: Activity assessments.
di: Jenny L Wilkerson, et al.
Pubblicazione: (2019-01-01)

Detection of Δ9-tetrahydrocannabinol (THC) in hair using GC–MS
di: Himanshu Khajuria, et al.
Pubblicazione: (2014-03-01)

The neural basis of resting-state fMRI functional connectivity in fronto-limbic circuits revealed by chemogenetic manipulation
di: Catherine Elorette, et al.
Pubblicazione: (2024-05-01)

Miswiring the brain: Human prenatal Δ9-tetrahydrocannabinol use associated with altered fetal hippocampal brain network connectivity
di: Moriah E. Thomason, et al.
Pubblicazione: (2021-10-01)

Loss of 'small-world' networks in Alzheimer's disease: graph analysis of FMRI resting-state functional connectivity.
di: Ernesto J Sanz-Arigita, et al.
Pubblicazione: (2010-11-01)

Hydroxylation and glycosylation of Δ9-tetrahydrocannabinol by Catharanthus roseus cell suspension culture
di: Akhtar, Muhammad Tayyab, et al.
Pubblicazione: (2015)

Smoking or Vaping Cannabis and Cardiovascular Function: Is Δ‐9‐Tetrahydrocannabinol the Main Culprit?
di: Onyedika J. Ilonze, et al.
Pubblicazione: (2024-12-01)

Disease-modifying effects of natural Δ9-tetrahydrocannabinol in endometriosis-associated pain
di: Alejandra Escudero-Lara, et al.
Pubblicazione: (2020-01-01)

Cannabis Use and Neuroadaptation: A Call for Δ9-Tetrahydrocannabinol Challenge Studies
di: Johannes G. Ramaekers, et al.
Pubblicazione: (2022-04-01)

Adverse effects of Δ9-tetrahydrocannabinol on neuronal bioenergetics during postnatal development
di: Johannes Beiersdorf, et al.
Pubblicazione: (2020-12-01)

Modafinil alters intrinsic functional connectivity of the right posterior insula: a pharmacological resting state fMRI study.
di: Nicoletta Cera, et al.
Pubblicazione: (2014-01-01)

Proteomic Profile of Circulating Extracellular Vesicles in the Brain after Δ9-Tetrahydrocannabinol Inhalation
di: Valeria Lallai, et al.
Pubblicazione: (2024-09-01)

Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review
di: Lourdes Poyatos, et al.
Pubblicazione: (2020-06-01)

Neuronal and Astrocytic Morphological Alterations Driven by Prolonged Exposure with Δ9-Tetrahydrocannabinol but Not Cannabidiol
di: Elisa Landucci, et al.
Pubblicazione: (2022-01-01)

Screening microbially produced Δ9-tetrahydrocannabinol using a yeast biosensor workflow
di: William M. Shaw, et al.
Pubblicazione: (2022-09-01)

A Systematic Review and Meta-Analysis of the In Vivo Haemodynamic Effects of Δ9-Tetrahydrocannabinol
di: Salahaden R. Sultan, et al.
Pubblicazione: (2018-01-01)

Anticancer activity of Δ9-tetrahydrocannabinol and cannabinol in vitro and in human lung cancer xenograft
di: Surang Leelawat, et al.
Pubblicazione: (2022-01-01)

Δ9-Tetrahydrocannabinol content in cannabis samples seized in Novi Sad during 2008
di: MAJA DJURENDIĆ-BRENESEL, et al.
Pubblicazione: (2010-07-01)

Single and Synergistic Effects of Cannabidiol and Δ-9-Tetrahydrocannabinol on Zebrafish Models of Neuro-Hyperactivity
di: Éric Samarut, et al.
Pubblicazione: (2019-03-01)

Suppression of STAT3 Signaling by Δ9-Tetrahydrocannabinol (THC) Induces Trophoblast Dysfunction
di: Xinwen Chang, et al.
Pubblicazione: (2017-06-01)

Default mode network in the effects of Δ9-Tetrahydrocannabinol (THC) on human executive function.
di: Matthijs G Bossong, et al.
Pubblicazione: (2013-01-01)

Evaluation of Δ9-tetrahydrocannabinol metabolites and oxidative stress in type 2 diabetic rats
di: Zeynep Coskun, et al.
Pubblicazione: (2016-02-01)

Arousal Contributions to Resting-State fMRI Connectivity and Dynamics
di: Yameng Gu, et al.
Pubblicazione: (2019-11-01)

State-Dependent Effective Connectivity in Resting-State fMRI
di: Hae-Jeong Park, et al.
Pubblicazione: (2021-10-01)

Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, Δ9-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract
di: Joseph J. Wakshlag, et al.
Pubblicazione: (2020-09-01)

Development of a plant-produced recombinant monoclonal antibody against Δ-9-tetrahydrocannabinol (Δ9-THC) for immunoassay application
di: Wanuttha Boonyayothin, et al.
Pubblicazione: (2022-06-01)